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Computerised Cognitive Behaviour Therapy for 
Depression 
 
Patient Information Sheet 
 
We would like to invite you to take part in a research study.  Before you 
decide it is important for you to understand why the research is being done 
and what it would involve for you.  Please take time to read the following 
information carefully. Feel free to discuss the study with your family, friends or 
GP.     
• Part 1 tells you the purpose of this study and what will happen to you if you 
take part.   
• Part 2 gives you more detailed information about the way in which the 
study will be run. 
 
Ask us if there is anything that is not clear or if you would like more 
information.  Our contact details can be found on Page 8. Take time to decide 
whether or not you wish to take part. 
 
Part 1: General Information 
 
What is the purpose of the study? 
 
Depression causes misery to many people and is a major health problem in 
the UK.  The majority of people with depression receive care from their GP, 
and never really see a specialist. However, lots of people experiencing 
depression would also like to receive a “talking treatment” (counselling or 
psychotherapy). Cognitive Behaviour Therapy (CBT) seems to be the most 
effective type of talking treatment for depression but is not always immediately 
available in the NHS.  
Recently, therapists have developed a form of CBT that can be delivered by 
computer, which might make it easier to access this form of treatment.  We 
call this “computerised CBT”.  There are different computerised packages, 
which can be used in your own home or in your GP practice.  At the moment 
we do not yet know which of these works best for NHS patients with 
depression. 
Computerised CBT is recommended by the National Institute for Clinical 
Excellence (NICE) for people experiencing depression, but we need more 
information about how effective it is.  We would also like to know how different 
computerised CBT packages compare.  This is important for the NHS to 
know, when deciding whether to offer this treatment in General Practice. 
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The purpose of this study is to compare two commonly used CBT packages to 
see if there are any additional benefits of offering this treatment to the care 
that people already receive from their General Practitioner. 
 
Why have I been invited? 
 
Your GP is taking part in this study and has identified you as suffering from 
depression.  We are planning to recruit 690 people with depression to take 
part in the study. 
 
Do I have to take part? 
 
It is up to you to decide.  We will describe the study and go through this 
information sheet with you.  We will then ask you to sign a consent form to 
show you have agreed to take part.  You are free to withdraw at any time, 
without giving a reason.  This would not affect the standard or type of care 
you receive.   
 
What will happen to me if I take part? 
This study is a randomised controlled trial.  Sometimes we don’t know which 
way of treating patients is best. To find out, we need to compare different 
treatments. We put patients into groups and give each group a different 
treatment.  The results are compared to see if one is better, or if they are all 
equally as effective. To try to make sure the groups are the same to start with, 
each patient is put into a group by chance (randomly).  We will be putting 
patients into one of three groups (usual GP care alone, or one of two forms of 
computerised CBT plus usual GP care).  A third of all study participants (230) 
will go into each group. You therefore have a one-in-three chance of going 
into a particular group. 
 
Firstly we will ask you some brief questions over the telephone to see if you 
are likely to be eligible for the study. We will then interview you at a venue you 
choose.  We will ask for your consent to ask you some questions to check that 
you are definitely eligible for the study.  If you are eligible we will then ask for 
your consent to enter you into the study. We will then ask you to fill in some 
questionnaires (we can help you with this if necessary) and we will make a 
telephone call to find out which treatment group to put you in. We will then let 
you know how to access your treatment.  This first interview will last about an 
hour. 
 
After the initial interview patients in the usual GP care group will continue to 
receive care for their depression from their GP. Patients receiving one form of 
computerised CBT (Beating the Blues) will attend 8 sessions of therapy at a 
convenient location. Each session will last about an hour and there will be 
some ‘homework’ to be done between sessions. If patients have a home 
computer and Internet connection, these sessions can be done online at 
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home.  Patients receiving the other form of computerised CBT (MoodGYM) 
will attend 6 sessions of therapy at a convenient location. Each session will 
last about an hour and there will be some ‘homework’ to be done between 
sessions. Again if you have a computer and Internet connection, these 
sessions can be done online at home.  
If you receive computerised CBT, we will also telephone you several times 
over the course of the therapy to make sure that you are not having any 
problems with the programs.  If you give consent, we would like to record 
these phone calls so that we can supervise the member of staff making the 
calls. These tapes will be typed up and the transcripts read by members of the 
research team. All the information in these transcripts will be made 
anonymous. The tapes will then be destroyed.   
If you do not consent to having these calls recorded, you can still participate in 
the trial. 
After four months we will contact you again to ask you a further set of 
questions to see how you are feeling now.   We will also do this at 12 months 
and 24 months after you have entered the study.  We can interview you face-
to-face or over the telephone to  ask you these questions.  Each of these 
follow-up visits or telephone calls will take about half an hour. Alternatively, 
we can send the questionnaires to you in the post with a stamped addressed 
envelope. You can then complete them and return them to us. You will be 
able to let us know how you would like to get the information to us. 
We will need to collect some information from your medical records to find out 
what NHS services you have used while you have been participating in the 
study and if you have been prescribed any antidepressant medication. This 
will help us to work out which treatment is the best value for money.   Overall 
the research study will last for four and a half years. Your involvement will 
only be for 24 months. At the end of the study we will send you a written 
summary of our findings, if you would like one. 
Throughout the study you will continue to be looked after by your GP, as 
normal.  You can see your GP as often as you and he/she thinks necessary 
 
Expenses and payments 
 
Unfortunately, we are not able to offer any expenses or payments to patients 
who participate in the study. 
 
What will I have to do? 
 
We would like you to be available for the interviews with our researchers, 
whether these are face-to-face or over the telephone. If you decide to receive 
follow-up questionnaires in the post, we would like you to complete these as 
fully as possible and return them to us. We would also like you to complete 
the treatment that you have been allocated to. You are able to take any  
prescribed or over-the-counter drugs. You are also free to try any other type 
of therapy for your depression. 
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What is the treatment that is being tested? 
 
We are testing two different types of CBT packages, Beating the Blues and 
MoodGYM, against the usual treatment, GP care.  Each of these involves a 
number of interactive therapy sessions and a small amount of ‘homework’ 
between sessions.  We know from research already conducted that each of 
these are effective ways of treating depression, but we do not know which is 
the best or if they are all equally effective. 
 
What are the alternatives for treatments? 
 
People with depression are generally offered either antidepressant medication 
or some form of talking treatment (psychotherapy or counseling) delivered by 
a healthcare professional working in a GP practice.  Sometimes people 
receive both medication and talking treatment.  For various reasons, the 
availability of talking treatments is sometimes limited in the NHS, and patients 
sometimes have to wait until a healthcare professional is available to offer this 
treatment.  By participating in this trial, you will still have access to all of these 
alternatives if the treatment that you are allocated does not work or is not one 
which you find helpful. 
 
What are the possible disadvantages and risks of taking part? 
We know from many research studies that usual GP care is generally 
effective in treating depression.  The research supporting the use of 
computerised CBT has only been conducted more recently and we are less 
sure how effective computerised CBT is if added to usual GP care, and who it 
works best for.  If you are allocated computerised CBT, we will ask you to try 
this treatment. 
Computerised CBT has been designed to be easy to use, even if you have no 
experience of using computers.  If you are allocated this treatment, you may 
not like this method of treatment.  If this is the case, we may ask you more 
about this to help us understand people’s experience of computerised CBT in 
more detail.  You will still have access to the full range of treatment options 
that are available to other people in your GP practice throughout the trial if this 
is the case. 
 
What are the side effects of any treatment received when taking part? 
 
There are no known side effects of computerised CBT.    
 
What are the possible benefits of taking part? 
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We cannot promise that the study will help you as we do not whether 
computerised CBT is better than the usual treatment..  However, we know 
from existing research that both computerised CBT and the usual treatment 
generally help people with depression. The information we get from this study 
will help improve the treatment of people with depression. 
The computerised form of treatment has been officially recommended for use 
in the NHS, but we know that this form of treatment is still not universally 
available.  By participating in this trial, you may well therefore get access to a 
treatment that might not otherwise be available in your GP practice or area.   
 
What happens when the research study stops? 
Our study is only funded for a limited period of time.  When the study is 
completed, we will no longer be in a position to offer computerised therapy in 
your GP practice.  If your GP practice has found the service helpful in 
improving access to care, then they may well wish to offer this treatment on a 
routine basis.  We will have helped them to make it easier to set up a 
computerised CBT service during the time that they have participated in this 
study. 
 
What if there is a problem? 
 
We will address any complaint about the way you have been dealt with during 
the study or any possible harm you might suffer.   Detailed information on this 
is given in Part 2. 
 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will 
be handled in confidence.  The details are included in Part 2. 
 
This completes Part 1. If this information has interested you and you are 
considering whether to participate, please read the additional information in 
Part 2 before making any decision. 
 
 
Part 2: Detailed Information 
 
What if relevant new information becomes available? 
 
Sometimes we get new information about the treatment being studied.  If this 
happens, the research team will tell you and discuss whether you should 
continue in the study.  If you decide not to carry on, your usual GP care will  
continue.  If you decide to continue in the study, we may ask you to sign an 
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updated consent form. If we think you should withdraw from the study, we will 
explain the reasons and arrange for your care to continue. 
 
If the study is stopped for any other reason, we will tell you and arrange your 
continuing care. 
 
What will happen if I don’t want to carry on with the study? 
 
You are free to withdraw from the treatment that you are receiving at any time.  
If you do, it is still important for us to carry out the follow-up interviews with 
you. If you do not want to be interviewed, you are free to refuse. We would 
still like to be able to use the data that we have collected about you. 
 
What if there is a problem? 
 
If you have a concern about any aspect of this study, you should ask to speak 
to the researcher who will do their best to answer your questions (contact 
number). If you do not want to speak to the researcher you can contact the 
local principal investigator (name and contact details) or the chief investigator, 
Professor Simon Gilbody (telephone number: 01904 321370, email: 
simon.gilbody@york.ac.uk. If you remain unhappy and wish to complain 
formally, you can do this through the NHS Complaints Procedure. You can 
obtain details from your GP surgery. 
 
In the event that something goes wrong and you are harmed during the 
research and this is due to someone’s negligence then you may have grounds 
for a legal action for compensation against the University of York or your 
clinician.   
 
 
Will my taking part in the study be kept confidential? 
 
All information collected about you during the course of the research will be 
kept strictly confidential. We will keep the information we collect about you 
separate from your contact details and we will only link this information 
together with a secure code.  We will store all information securely. At the end 
of the study, researchers from the University of York will need to have access 
to your medical records to see what NHS services you have used during the 
study.   
 
We will use the information we collect to decide how effective each of the 
treatments are that we are testing.  We will keep it for 20 years and then 
destroy it securely.  We will destroy all contact information immediately after 
the end of the study. 
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You have the right to check the accuracy of data held about you and correct 
any errors.  
 
Involvement of your GP 
 
We will inform your GP if you agree to participate in the trial and if you decide 
to withdraw. We will also inform them about which treatment group you have 
been allocated to. He/she will need this information when looking after you. If, 
we are worried that you are having thoughts about harming yourself, we may 
need to discuss these with your GP. We will of course discuss this with you. 
If you send us questionnaires through the post and we are worried that you 
are having thoughts about harming yourself, we will make every effort to 
contact you on the telephone to discuss these thoughts. If we are unable to 
contact you quickly, we will let your GP know of our concerns. 
 
What will happen to the results of the research study? 
 
We will publish the results of this research study widely. As well as producing 
a research report and writing articles for health professionals to read, you will 
be given a summary of the findings. We will ensure charities such as 
Depression Alliance are informed of the results of the trial.  You will not be 
personally identified in any publications from this trial. 
 
Who is organizing and funding the research? 
 
The University of York is organizing this research. The funder is the Health 
Technology Assessment (HTA) Programme. We will pay your GP for the work 
that he/she and the practice staff do as part of the study. 
 
Who has reviewed the study? 
 
All research in the NHS is looked at by an independent group of people, 
called a Research Ethics Committee to protect your safety, rights, wellbeing 
and dignity.  This study has been reviewed and given favourable opinion by 
Leeds (East) Research Ethics Committee. 
 
Further information and contact details 
 
For further general information about research, please see the INVOLVE 
website at http://www.invo.org.uk 
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For specific information about this research study, please contact 
 
Liz Littlewood 
Trial Manager 
Area 4, Seebohm Rowntree Building 
Department of Health Sciences 
University of York 
York, YO10 5DD  
 
Telephone: 01904 321828 
Email: liz.littlewood@york.ac.uk 
 
For advice about whether you should participate, please speak to the local 
researcher or your own GP. 
 
If you have a concern about any aspect of this study, please see the contact 
details given on Page 6 of this information sheet. 
 
Thank you for reading this and for considering taking part in this study.  
  
  
